Mirae Asset Global Investments Co., Ltd. Ionis Pharmaceuticals Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,358 shares of IONS stock, worth $180,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,358
Previous 15,081
71.1%
Holding current value
$180,900
Previous $653,000
68.3%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding IONS
# of Institutions
394Shares Held
125MCall Options Held
2.25MPut Options Held
510K-
Vanguard Group Inc Valley Forge, PA13.8MShares$575 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$525 Million0.38% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$428 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.26MShares$343 Million6.59% of portfolio
-
Wellington Management Group LLP Boston, MA6.57MShares$273 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.89B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...